VR Adviser, LLC

SEC CIK: 0001615982
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by VR Adviser, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overview All 13F holders of AVTX Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2023

Holdings of AVTX by VR Adviser, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−1,250,000−100.0%	Sold out	Holders
Q2 2023	1,250,000	$444.0K	0.1%	+250,000+25.0%	Added	Holders
Q1 2023	1,000,000	$1.75M	0.3%	+1,000,000	New	Holders